ELEV Financial Statements

Balance sheet, income statement, cash flow, and dividends for Elevation Oncology Inc (ELEV).


$33.26M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

ELEV Market Cap. (MRY)


ELEV Shares Outstanding (MRY)


ELEV Assets (MRY)


Total Assets

$95.63M

Total Liabilities

$35.60M

Total Investments

$43.72M

ELEV Income (MRY)


Revenue

$0

Net Income

-$44.48M

Operating Expense

$44.70M

ELEV Cash Flow (MRY)


CF Operations

-$36.36M

CF Investing

-$8.37M

CF Financing

$44.94M

ELEV Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

ELEV Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$95,626,000 (7.34%)

$89,091,000 (-5.38%)

$94,161,000 (-37.01%)

$149,494,000 (84.77%)

Assets Current

$94,726,000 (7.69%)

$87,964,000 (-5.39%)

$92,977,000 (-37.78%)

$149,424,000 (84.96%)

Assets Non-Current

$900,000 (-20.14%)

$1,127,000 (-4.81%)

$1,184,000 (1591.43%)

$70,000 (-42.15%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$60,025,000 (9.52%)

$54,809,000 (11.78%)

$49,032,000 (-65.15%)

$140,697,000 (709.58%)

Property Plant & Equipment Net

$34,000 (-42.37%)

$59,000 (-39.80%)

$98,000 (157.89%)

$38,000 (-32.14%)

Cash & Equivalents

$49,464,000 (0.42%)

$49,255,000 (7.27%)

$45,917,000 (-68.61%)

$146,284,000 (84.24%)

Accumulated Other Comprehensive Income

$61,000 (577.78%)

$9,000 (105.59%)

-$161,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$43,720,000 (29.15%)

$33,852,000 (-23.69%)

$44,363,000 (0%)

$0 (0%)

Investments Current

$43,720,000 (29.15%)

$33,852,000 (-23.69%)

$44,363,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$559,000 (10.26%)

$507,000 (-92.03%)

$6,362,000 (12.64%)

$5,648,000 (-0.55%)

Accumulated Retained Earnings (Deficit)

-$240,455,000 (-22.70%)

-$195,970,000 (-30.42%)

-$150,266,000 (-172.29%)

-$55,186,000 (-138.42%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$31,134,000 (3.31%)

$30,137,000 (2.38%)

$29,435,000 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$31,134,000 (3.31%)

$30,137,000 (2.38%)

$29,435,000 (0%)

$0 (0%)

Total Liabilities

$35,601,000 (3.85%)

$34,282,000 (-24.04%)

$45,129,000 (413.00%)

$8,797,000 (29.37%)

Liabilities Current

$4,467,000 (7.77%)

$4,145,000 (-73.59%)

$15,692,000 (78.54%)

$8,789,000 (29.54%)

Liabilities Non-Current

$31,134,000 (3.31%)

$30,137,000 (2.38%)

$29,437,000 (367862.50%)

$8,000 (-46.67%)

ELEV Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$16,106,000 (8.06%)

$14,904,000 (-5.86%)

$15,832,000 (87.34%)

$8,451,000 (369.50%)

Research & Development Expense

$28,597,000 (12.44%)

$25,434,000 (-67.69%)

$78,717,000 (233.62%)

$23,595,000 (52.46%)

Operating Expenses

$44,703,000 (-1.63%)

$45,445,000 (-51.93%)

$94,549,000 (195.04%)

$32,046,000 (85.49%)

Interest Expense

$1,203,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$43,000 (43.33%)

$30,000 (20.00%)

$25,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$44,485,000 (2.67%)

-$45,704,000 (51.93%)

-$95,080,000 (-196.76%)

-$32,039,000 (-85.57%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$44,485,000 (2.67%)

-$45,704,000 (51.93%)

-$95,080,000 (-196.76%)

-$32,039,000 (-85.57%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$44,485,000 (2.67%)

-$45,704,000 (51.93%)

-$95,080,000 (-196.76%)

-$32,039,000 (-85.57%)

Weighted Average Shares

$57,275,454 (68.07%)

$34,077,675 (46.46%)

$23,267,120 (91.77%)

$12,132,610 (1432.24%)

Weighted Average Shares Diluted

$57,275,454 (68.07%)

$34,077,675 (46.46%)

$23,267,120 (91.77%)

$12,132,610 (1432.24%)

Earning Before Interest & Taxes (EBIT)

-$43,239,000 (5.33%)

-$45,674,000 (51.95%)

-$95,055,000 (-196.69%)

-$32,039,000 (-85.57%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$44,703,000 (1.63%)

-$45,445,000 (51.93%)

-$94,549,000 (-195.04%)

-$32,046,000 (-85.49%)

ELEV Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$8,365,000 (-172.47%)

$11,543,000 (126.00%)

-$44,398,000 (0%)

$0 (0%)

Net Cash Flow from Financing

$44,938,000 (-6.33%)

$47,975,000 (62.55%)

$29,514,000 (-69.59%)

$97,051,000 (7.80%)

Net Cash Flow from Operations

-$36,364,000 (35.27%)

-$56,180,000 (34.28%)

-$85,483,000 (-183.37%)

-$30,167,000 (-145.30%)

Net Cash Flow / Change in Cash & Cash Equivalents

$209,000 (-93.74%)

$3,338,000 (103.33%)

-$100,367,000 (-250.06%)

$66,884,000 (-13.88%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$8,365,000 (-172.47%)

$11,543,000 (126.05%)

-$44,312,000 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

-$86,000 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$170,000 (0%)

$0 (0%)

$29,530,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$44,609,000 (-4.02%)

$46,479,000 (132897.14%)

-$35,000 (-100.04%)

$97,062,000 (485210.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$4,280,000 (28.34%)

$3,335,000 (4.02%)

$3,206,000 (104.07%)

$1,571,000 (2921.15%)

Depreciation Amortization & Accretion

$24,000 (-38.46%)

$39,000 (44.44%)

$27,000 (50.00%)

$18,000 (20.00%)

ELEV Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-62.20% (24.05%)

-81.90% (25.75%)

-110.30% (-259.28%)

-30.70% (-125.73%)

Return on Average Assets (ROAA)

-41.80% (13.99%)

-48.60% (40.73%)

-82.00% (-244.54%)

-23.80% (42.93%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-60.40% (35.26%)

-93.30% (37.00%)

-148.10% (-116.90%)

876.40% (44.69%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.72 (-79.80%)

-0.4 (-72.84%)

-0.23 (89.82%)

-2.28

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.55 (33.17%)

0.42 (-7.76%)

0.45 (-54.63%)

0.99

Debt to Equity Ratio (D/E)

0.59 (-5.12%)

0.63 (-32.07%)

0.92 (1360.32%)

0.06 (121.36%)

Earnings Per Share (EPS)

-0.78 (41.79%)

-1.34 (67.24%)

-4.09 (-54.92%)

-2.64 (87.89%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.64 (61.49%)

-1.65 (55.17%)

-3.68 (-47.95%)

-2.49 (84.09%)

Book Value Per Share (BVPS)

1.05 (-34.83%)

1.61 (-23.68%)

2.11 (-81.83%)

11.6 (139.79%)

Tangible Assets Book Value Per Share (TABVPS)

1.67 (-36.11%)

2.61 (-35.41%)

4.05 (-67.16%)

12.32 (-87.94%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

0

Enterprise Value Over EBITDA (EV/EBITDA)

-0.37 (-891.49%)

0.05 (291.67%)

0.01 (-97.50%)

0.48

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

21.21 (-0.08%)

21.22 (258.18%)

5.92 (-65.15%)

17 (42.78%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$36,364,000 (35.27%)

-$56,180,000 (34.35%)

-$85,569,000 (-183.65%)

-$30,167,000 (-143.89%)

Enterprise Value (EV)

$16,079,380 (848.13%)

-$2,149,284 (-81.34%)

-$1,185,244 (92.29%)

-$15,379,665

Earnings Before Tax (EBT)

-$44,442,000 (2.70%)

-$45,674,000 (51.95%)

-$95,055,000 (-196.69%)

-$32,039,000 (-85.57%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$43,215,000 (5.30%)

-$45,635,000 (51.98%)

-$95,028,000 (-196.77%)

-$32,021,000 (-85.63%)

Invested Capital

$72,829,000 (10.64%)

$65,828,000 (6.20%)

$61,987,000 (1211.08%)

-$5,579,000 (-5.70%)

Working Capital

$90,259,000 (7.68%)

$83,819,000 (8.45%)

$77,285,000 (-45.05%)

$140,635,000 (90.04%)

Tangible Asset Value

$95,626,000 (7.34%)

$89,091,000 (-5.38%)

$94,161,000 (-37.01%)

$149,494,000 (84.77%)

Market Capitalization

$33,260,380 (46.03%)

$22,776,716 (2.90%)

$22,135,756 (-84.17%)

$139,818,335

Average Equity

$71,529,000 (28.21%)

$55,792,500 (-35.26%)

$86,175,500 (-17.45%)

$104,389,250 (821.07%)

Average Assets

$106,371,500 (13.06%)

$94,083,500 (-18.85%)

$115,935,750 (-13.94%)

$134,709,000 (225.30%)

Invested Capital Average

$71,533,250 (46.19%)

$48,933,000 (-23.76%)

$64,182,250 (1855.65%)

-$3,655,750 (-28.25%)

Shares

59,119,055 (39.38%)

42,414,741 (82.03%)

23,300,796 (0.32%)

23,225,637 (1.77%)